Related references
Note: Only part of the references are listed.Upregulation of MicroRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1
Fan Li et al.
FEBS LETTERS (2014)
miR-103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4
Hsin-Yi Chen et al.
CANCER RESEARCH (2012)
The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
Toshio Shimizu et al.
CLINICAL CANCER RESEARCH (2012)
Association between the miRNA signatures in plasma and bronchoalveolar fluid in respiratory pathologies
Sonia Molina-Pinelo et al.
DISEASE MARKERS (2012)
microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cε
J. Datta et al.
ONCOGENE (2012)
High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease
Annamaria Ruzzo et al.
ONCOLOGIST (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Treatment recommendations for metastatic colorectal cancer
Enrique Aranda et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
miRWalk - Database: Prediction of possible miRNA binding sites by walking the genes of three genomes
Harsh Dweep et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2011)
Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype
I. Van der Auwera et al.
BRITISH JOURNAL OF CANCER (2010)
Novel Agents in the Treatment of Metastatic Colorectal Cancer
Stephen Leong et al.
CANCER JOURNAL (2010)
SEOM clinical guidelines for the treatment of advanced colorectal cancer
Rocio Garcia-Carbonero et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
The PKB/AKT Pathway in Cancer
Amancio Carnero
CURRENT PHARMACEUTICAL DESIGN (2010)
Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
Marco Ragusa et al.
MOLECULAR CANCER THERAPEUTICS (2010)
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer
D. Cunningham et al.
ANNALS OF ONCOLOGY (2009)
The miR-18a*microRNA functions as a potential tumor suppressor by targeting on K-Ras
Wing Pui Tsang et al.
CARCINOGENESIS (2009)
Inhibiting PI3K as a therapeutic strategy against cancer
Luis Paz-Ares et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Novel inhibitors of the PI3K family
Amancio Carnero
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
MicroRNAs in colorectal cancer: translation of molecular biology into clinical application
Ondrej Slaby et al.
MOLECULAR CANCER (2009)
Role of miR-143 targeting KRAS in colorectal tumorigenesis
X. Chen et al.
ONCOGENE (2009)
Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer
Remco Nagel et al.
CANCER RESEARCH (2008)
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
Ulrike Burk et al.
EMBO REPORTS (2008)
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers
Chunguang Guo et al.
GENES CHROMOSOMES & CANCER (2008)
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Qihong Huang et al.
NATURE CELL BIOLOGY (2008)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
Targeted disruption of protein kinase Cε reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma
Quintin Pan et al.
CANCER RESEARCH (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
RAS is regulated by the let-7 MicroRNA family
SM Johnson et al.
CELL (2005)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Heterogeneous vascular dependence of tumor cell populations
JL Yu et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
LB Saltz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
Share Paper
